Clinical Relevance of Histopathologic Analysis of HeartMate II Thrombi

Lisa Baumann Kreuziger1,2, Mark S Slaughter3, Kartik Sundareswaran4

  • 1From the BloodCenter of Wisconsin, Milwaukee, Wisconsin.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|February 21, 2018
PubMed

Insights

Left ventricular assist device (LVAD) thrombosis is a serious complication. This study found fibrin-rich thrombi on HeartMate II LVAD rotors, suggesting new anticoagulation strategies are needed.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Hematology

Background:

  • Left ventricular assist device (LVAD) thrombosis affects 10% of patients despite current treatments.
  • The initiation and propagation mechanisms of LVAD thrombosis remain unclear.

Purpose of the Study:

  • To investigate the pathological characteristics and formation mechanisms of LVAD thrombi.
  • To identify potential targets for improved anticoagulation strategies.

Main Methods:

  • Pathological and immunohistochemical examination of 28 thrombi from 17 HeartMate II LVADs.
  • Classification of thrombi based on location (inlet/outlet vs. rotor).

Main Results:

  • Two distinct thrombus types were identified: loose fibrin-rich thrombi in the inlet/outlet and laminated thrombi on the rotor.
  • Rotor thrombi, particularly at the inlet bearing, showed ring-like structures with fibrin and von Willebrand factor internally and increased platelets externally.
  • The laminated structure suggests clot development over time.

Conclusions:

  • The fibrin-rich nature of HeartMate II thrombi indicates a need for alternative anticoagulation therapies.
  • Further research into the role of platelets in thrombus growth at the inlet bearing is warranted.

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
224
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Nursing Clinical Information System01:27

Nursing Clinical Information System

Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
1